Johji Nomura

Title: Johji Nomura: Innovator in Quaternary Ammonium Salt Compounds

Introduction

Johji Nomura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quaternary ammonium salt compounds. His research focuses on compounds that exhibit both β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.

Latest Patents

Nomura holds a patent for quaternary ammonium salt compounds, which are represented by a specific formula. The primary objective of this invention is to provide a novel compound that demonstrates superior β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. This advancement has potential implications in the development of new therapeutic agents.

Career Highlights

Johji Nomura is associated with Teijin Pharma Limited, a prominent company in the pharmaceutical industry. His work at Teijin Pharma has allowed him to explore and develop innovative solutions in drug formulation and delivery.

Collaborations

Throughout his career, Nomura has collaborated with esteemed colleagues, including Junji Igarashi and Hiroyuki Sugiyama. These collaborations have fostered a productive environment for research and development in their respective fields.

Conclusion

Johji Nomura's contributions to the field of pharmaceutical chemistry, particularly through his patent on quaternary ammonium salt compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.